A lactococcal expression system was developed which allows the exclusive production of novel nisins encoded by mutated pre-nisin (nisA) genes. This system is based on a combination of a specifically constructed host strain and vectors which facilitate the genetic manipulation of the nisA gene. The wildtype chromosomal gene is effectively replaced with a variant nisA gene, by the technique of gene replacement. The recovery of full nisin immunity was employed as a means of directly selecting strains that had acquired an intact nisA gene by the gene replacement process. With this approach the other genes required for pre-nisin maturation are not affected and any alterations to DNA sequences are restricted to only those specific mutations introduced in the nisA gene. The effectiveness of the system was demonstrated by the expression of a number of variant nisA genes leading to the successful production and characterization of nisins containing the substitutions Dha5A, Dha33A, Dha5,33A, H27K, 130W and K12L. The enhanced yields of these engineered nisin molecules, when compared to their production in a plasmidcomplementation system, underlines the improvement offered by this gene replacement strategy.
INTRODUCTION
The lantibiotic nisin, produced by Lactococczrs lactis, exhibits antimicrobial activity against a wide range of Gram-positive bacteria. Its ability to inhibit the growth of spoilage bacteria and food pathogens has resulted in the extensive use of nisin as a natural preservative in certain food products. With the advances made in the genetic analysis of nisin biosynthesis it has become possible to develop protein engineering strategies aimed at altering the biological properties of nisin (Dodd & Gasson, 1994; Rauch e t al., 1994) . Studies of this type lead the way to an investigation of the structure-function relationships of this complex molecule. Furthermore, protein engineering may result in the construction of nisin variants that display altered biological activities or other advantageous properties extending its use as a broad-spectrum antimicrobial agent.
The nature of lantibiotic biosynthesis requires that expression systems for protein engineering must encode all the necessary maturation machinery for these postAbbreviations: Dha, Dehydroalanine; Dhb Dehydrobutyrine. translationally modified and secreted antimicrobial peptides. For nisin biosynthesis it has been established that, in addition to the structural gene nzsA, at least ten additional genes are involved in production of the mature molecule (Kuipers e t a/., 1993; Engelke e t al., 1994; Siegers & Entian, 1995) . Nisin-producing strains, carrying plasmidencoded variant nisA genes, have been employed for the production of engineered nisins, in addition to the wildtype nisin expressed by the resident gene (Kuipers et al., 1992) . We have previously described the development of a Nis-lactococcal expression system in which the nisA gene of the host, FI7332, was insertionally inactivated (Dodd e t a/., 1992) . This deficiency can be complemented by provision of a plasmid-encoded nisA gene which has been subjected to site-specific mutagenesis. With this approach, only the product of the variant nisA gene is subject to the processing specified by the other Nis proteins. Hence, this strategy has the advantage of ensuring the exclusive expression of a variant pre-nisin and furthermore allowed an instant assessment to be made of the activity of the mature modified peptide (Dodd e t al,, 1992) . The construction of a similar lactococcal strain has been described which contains an inactivated nisA gene (Kuipers e t al., 1993 
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n i s A and nisZ genes in this host has resulted in the successful production of nisin and nisin variants.
Here, we describe the development of an alternative lactococcal expression system in which the technique of gene replacement was used to incorporate a copy of the n i s A gene into a nisA-deficient nisin operon. Vectors have been constructed that facilitate the genetic manipulation of the nisA gene and enable these variant genes to be substituted for the chromosomal wild-type gene. To illustrate the use of this protein engineering strategy, the construction of a number of strains encoding variant nisA genes is described. A range of nisin variants have been produced with the aim of furthering investigations into the structure-function relationships and mode of action of this complex molecule. The expression and production of these engineered nisins, as compared to that achieved in the previously reported plasmid-complementation system (Dodd e t a/., 1992 (Dodd e t a/., , 1995 , is discussed.
Microbiological techniques and strains used. The lactococcal strains used in this study and their derivation are given in Table  1 . Unless stated otherwise, cultures were grown at 30 "C in M17 medium (Terzaghi & Sandine, 1975) supplemented with 0.5 YO (w/v) glucose (GM17 medium). Screening strains for resistance to antibiotics was carried out at the following levels: erythromycin, (Em") 5 pg ml-'; streptomycin, (Sm") 200 pg ml-'. , 1980) was the host strain for construction and molecular analysis of recombinant plasmids derived from the vectors pMTL23p (Chambers et al., 1988) , pGEM-32 (Promega), pCR I1 (Invitrogen) and pG'host6 (Appligene). Recombinant plasmids used, and constructed during the course of this study, are shown in Fig. 1 . E. coli cultures were propagated at 37 "C in L broth (Lennox, 1955) . Selection for ampicillin resistance (Ap') was with 200 pg ampicillin ml-' and selection for erythromycin resistance (Em") was with 400 pg erythromycin ml-'.
The production of active nisin by lactococcal strains was assayed by both deferred and direct means. Plate diffusion bioassays were performed as previously described (Dodd et al., 1992) . Colonies growing on the surface of a GM17 plate were directly assayed by inverting over chloroform for 12 min and overlaying with agar seeded with the nisin-sensitive L. lactis strain MG1614. Plates were incubated overnight and zone sizes around colonies were compared with those of controls. Nisin immunity was determined by streaking cultures on a series of GM17 agar plates containing an increasing concentration of nisin and assessing the degree of growth at the different nisin levels. Control cultures FI5876 (positive) and MG1614 (negative) were included on each plate. Nisin (50000 U mg-l) was kindly provided by Aplin & Barrett.
MICs were determined by assaying for growth inhibition in microtitre plates. Overnight cultures of sensitive indicator organisms were diluted to 1 in 100 either in GM17 broth for L. lactis MG1614 or in BHI broth for Micrococcus luteus NCIMB 8166 and 100 pl was added to each well. A dilution series of purified nisin and nisin variants (in duplicate) was added to the cell suspensions over a range of concentrations appropriate for detecting inhibition of growth. Plates were incubated at 30 "C for 8 h (with shaking for M . luteus) and OD,,, readings (Titertek multiskan NCC plate reader) were taken hourly. During this time growth of the indicator strain, in the absence of nisin, reached a maximum cell density and at this point the MIC value was taken as the lowest concentration of nisin, or nisin variant, which inhibited growth.
Molecular techniques.
Plasmid DNA isolation was carried out as described by Dodd e t al. (1990) and Horn e t al. (1991) . Restriction enzymes and other DNA-modifying enzymes from various sources were used according to the suppliers recommendations. Recombinant plasmids were recovered by transformation of E. coli as described previously by Dodd et al. (1 992) or by electroporation of L. lactis according to the method of (Fig. 2) . Primers P26 (5'-ATAGTTGACGAATATTTAA-TAATTTT) and P25 (5'-AATCGGATCCGTTTATTATG-CTCGC) were employed for amplification of the upstream 21 1 bp HincIIIBamHI fragment and primers P28 (5'GTTAGATCTGACATGGATAC) and P27 (5'-CTTGGTCGACACCATATTTT) were employed for the downstream 1.1 kb BglII/SalI fragment (relevant restriction enzyme sites are underlined). The template used for these PCRs was pFI172 DNA. The resulting plasmid, pFI740 (Fig. Id) , contained an intact nisA gene flanked by engineered BamHI and BglII sites, all contained within 2.1 kb of sequences homologous to the chromosome. Digestion of pFI740 with these two enzymes, followed by ligation of their compatible ends, resulted in the generation of plasmid pFI751 (Fig. le) in which the nisA gene has been deleted (designated AnisA). PCR amplification of this part of the plasmid and nucleotide sequence analysis of the region spanning the deletion in the amplified fragment confirmed that fusion of the BamHI and BglrI sites had occurred.
Construction of nisA site-specific mutations. The construction of the plasmid pFI877 (Fig. lc) allowed a cassette mutagenesis strategy to be employed for the introduction of site-specific mutations into the nisA gene. This pGEM-32-derivative contains the equivalent sequences to those in pFI690 (Fig. 1 b) , but includes the engineered BglII site downstream of nisA in pFI740 (Figs Id, 2) . In pFI877 a HincII/SacI fragment encoding the amino-terminal region of nisA and upstream expression signals, replaced the PCR-generated fragment of pFI740 that contains the engineered BamHI site. Thus, the only difference between sequences in pFI877 and the equivalent chromosomal wild-type sequences is the presence of an additional BglII site downstream of the nisA gene. Primers were designed for PCRmediated mutagenesis of the nisA cassette (Fig. 2) . The amplified cassette fragments, containing a specific mutation, were then substituted for the wild-type fragment of pFI877. The mutations nisAIS5A and nisAIK12L were incorporated in primers P17 (5'-TCAGAGCTCCTGTTTTACAACCGGGTGTACA-TAGTGCAAT) and PCJl (5'-TCAGAGCTCCTGTTAGA-CAAC), respectively (the sites of mutation are underlined). These primers, in conjunction with P26, were used to amplify the HincII/SacI cassette fragment. Primer PC J5 (5'-CAGG-AGCTCTGGGTTGTAACA) together with primer P32 generated a Sacl/BglII fragment containing the deletion mutation nisA/AM21. Other mutations required the technique of spliced-overlap extension with the specific mutations being incorporated on two complementary primers which span the mutation site (Dodd et al., 1992) . The mutations in nisA/S33A involved the primers P18 (5'-TAGTATTCACGTAGCTAA-ATAACC) and P19 (5'-TTGGTTATTTAGCTACGTGAA-TAC) ; nisA/I30W involved primers PC J6 (5'-CATTGTAGT-TGGCACGTAAGC) and PC 57 (5'-GCTTACGTGCCAACT-ACAATG) and nisAIH27K involved primers P58 (5'-CTTG-TAAATGTAGTATTCACGTAAG) and P59 (5'-CTTACG-TGAATACTACATTTACAAG). These mutations were contained within the Jacl/BglII fragment defined by primers P10 (5'-CAGGAGCTCTGATGGGTTG) and P32 (Fig. 2) . The PCR-generated fragments were cloned into the gene-replacement vector to create an uninterrupted coding region specifying the variant nisA gene. In the case of nisA/S5A,S33A both cassette fragments contained a mutation (Fig. 2) . After gene replacement, PCR analysis using P39 (5'-GACTTTC-CATTATGCTTGGATTTTT) and P40 (5'-GCTCCTATG- Conditions used for PCR were as described in Horn e t al. (1991) and primers were synthesized on an Applied Biosystems DNA synthesizer (model 381 A). Fragments generated for the construction of gene-replacement vectors were amplified using Dynazyme (Flowgen) and cloned into pCR I1 prior to nucleotide sequence confirmation. For routine PCR screening of recombinant clones AmpliTaq DNA polymerase (Perkin Elmer) was used. Direct nucleotide sequence determination of purified PCR-generated templates was carried out on an Applied Biosystems DNA Sequencer (model 373A) using the manufacturer's Taq DyeDeoxy Terminator Cycle sequencing kit. Construction of nisA gene-replacement vectors. The thermosensitive shuttle vector pG'host6 was employed for gene replacement. Homologous plasmid DNA originated from pFI172 (Dodd etal., 1990) which contains a 2.1 kb region of the FI5876 chromosome ( Fig. la) including the nisA gene. The entire fragment was subcloned into pG'host6 to generate the nisA gene-replacement vector pFI690 (Fig. 1 b) . Subsequent manipulation of this region, resulting in inactivation or mutagenesis of the nisA gene (see below), was carried out in either vector pGEM-32 or pMTL23P. The final step in the construction of each gene-replacement vector was cloning the modified 2.1 kb fragment into pG'host6. Construction of pF1751, AnisA gene-replacement vector. Inactivation of the nisA gene was achieved by deletion of the entire coding region. In order to confine the deletion to just nisA it was necessary to engineer additional restriction enzyme sites on either side of the gene. 
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ATTAClZAGTATTTCGCTATGTACACCCGGTTGTAAAACAGGAGCTCTGATGGGTTGTAACATGAAAACAGCAACTTGTCA 2 4 0 TAATGTTCATAAAGCGATACATGTGGGCCAACATTTTGTCCTCGAGACTACCCAACATTGTACTTTTGTCGTTGAACAGT Gene replacement protocol. L. lactis FI7990 transformants containing derivatives of pG'host6 were established at 28 "C and grown overnight at this temperature in GM17 containing 5 pg Em ml-' (GM17-Em). Approximately lo5 cells were used to inoculate 100 ml fresh, pre-warmed GM17-Em and the cultures were incubated at 28 "C for 4 h. Incubation was continued overnight at the elevated temperature of 37 "C. This temperature is non-permissive for pG'host6 replication (Biswas et al., 1993) , and the presence of Em in the growth medium ensures selection for those cell lines in which a single crossover results in the integration of the derivative in the chromosome at the site of plasmid/chromosome homology (Leenhouts et a/., 1989 (Leenhouts et a/., , 1990 Chopin et al., 1989) . Pre-warmed GM17 (with no Em) was inoculated with approximately lo5 cells from the overnight culture and incubated overnight at 28 "C. At this temperature, plasmid replication is possible and recombination between homologous sequences flanking the integrated plasmid results in its excision from the chromosome. Depending on where the second crossover occurs, either sequences originating from the integrated plasmid or the original sequences will be retained in the chromosome. Cultures were diluted and spread, to obtain single colonies, on GM17 agar plates. In order to cure the cells of plasmid, the plates were incubated at 37 "C. Colonies (approximately 50) were screened for loss of the pG'host6-derivative by patching onto GM17-Em plates. When using this technique to disrupt the nisA gene, colonies were also screened for loss of nisin activity and PCR analysis of the relevant region of the chromosome was used to confirm any changes at the molecular level.
Purification of engineered nisins. Nisin variants were purified from 1 1 of culture supernatants of producing strains by hydrophobic-interaction chromatography (Mulders et al., 1991) on a TSK Toyopearl Butyl 650M column (5 x 20 cm). Active fractions were lyophilized and further purified on a Waters pBondapak C18 reverse-phase semi-prep HPLC column (15 cm x 19 mm). The elution profile involved a linear gradient 25-50% buffer B (8 mM trifluoroacetic acid in 90%, v/v, aqueous acetonitrile) in buffer A (10 mM trifluoroacetic acid in l o % , v/v, aqueous acetonitrile) over 40 min at 2-0 ml min-l. The eluent was monitored at 195-300 nm using a scanning UV detector. The concentrations of nisin variants was confirmed by analytical HPLC with the area under the peak relating to the amount of nisin injected. Calibration curves were determined by injecting known concentrations of pure nisin variants.
RESULTS

Inactivation of chromosomally encoded F15876 nisA gene
The generation of a lactococcal host suitable for the production of engineered nisins involved adaptation of the well-characterized nisin-producing strain L. lactis FI5876 (Dodd e t al., 1990 ; Horn e t a/., 1991). In order to develop a gene replacement system for variant nisin expression it was necessary to first construct a Nis- in nisin production. The recovery of Nis' colonies hinged on the fact that these cells must necessarily also be immune to nisin at the level at which they were producing this antimicrobial peptide. In the modified gene replacement protocol the final step included the addition of nisin (to 10 pg ml-l) to the GM17 agar plates. Colonies that were immune to this level of nisin were screened for Em' and assayed for nisin production. PCR analysis was also used to determine the organization of genomic sequences. The effect of disruption of the nisA gene on immunity of the host strain to nisin has been described previously (Dodd e t al., 1992; Kuipers et al., 1993) and, as would be expected, FI7990 (AnisA) displayed reduced immunity. The construction of this strain involved primer 13 (Fig. 2) which was designed such that most of the proposed promoter region (Icuipers e t al., 1993) was deleted (Fig.  1) . The absence of these nisin expression signals resulted in FI7990 displaying significantly more sensitivity to nisin than strains that were Nis-as a result of insertion or frameshift mutations within the nisA gene. (Dodd e t al., 1992) . Sensitivity was evident at nisin concentrations above 5 pg ml-' compared to the wild-type strain which will continue growing in the presence of more than 50 pg nisin ml-' (Table 1) . Nis-strains that retained the upstream promoter sequences were immune to intermediate levels of nisin, the actual level being influenced by induction with nisin (H. M. Dodd, W. C. Chan, N. Horn & M. J. Gasson, unpublished data) . The fact that FI7990 was sensitive to the levels of nisin employed in the selection plates (10 pg ml-l) was crucial for the gene replacement procedure described above and ensured that it was possible to discriminate between the parent strain and derivatives that were producing an active nisin variant. derivative by inactivating the resident nisA gene of FI5876. Plasmid pFI751 (Fig. le) was constructed for this purpose and using gene replacement an approximately 300 bp deletion (designated AnisA, Fig. 2 ) was incorporated in the chromosome, in place of the nisA gene. Nis-strains, recovered at a frequency of about l o % , could be readily distinguished from the parent strain by PCR analysis. Primers P39 and P40 were designed from sequences located outside the region cloned into the genereplacement vectors (Fig. la) . Using these primers, a 1.8 kb fragment was amplified in the AnisA containing strains (Fig. 3 , track 4) compared to a 2.1 kb fragment generated from the equivalent region of FI5876, encoding wild-type nisA (Fig. 3, track 3 ). In one of the Nis-strains, designated FI7990, nucleotide sequence analysis of the PCR-generated 1.8 kb fragment confirmed that AnisA was incorporated in the correct region of the chromosome. The potential of FI7990 as an expression host for variant nisins was demonstrated by reverting the AnisA mutation to wild-type, in equivalent gene replacement experiments, using the vector pFI690 (Fig. lb) . The recovery of nisin production, by strain FI7898 (Table l) , indicated that the Nis-phenotype exhibited by FI7990 was due solely to the deletion that was previously introduced and that the other nisin-biosynthesisdeterminants were unaffected by the gene replacement process. PCR analysis of the Nis' colonies demonstrated that the AnisA mutation (1.8 kb fragment) had been replaced by the wild-type nisA gene (2.1 kb fragment). The use of PCR to readily identify strains at the molecular level that have undergone gene replacement (see Fig. 3 ) is a particular advantage of FI7990 as a host strain for engineering nisin. The low-level immunity to nisin was also displayed by the FI7990-derivative FI8003 (Table l) , in which the plasmid pFI740-encoded nisA (Fig. Id) was incorporated in the chromosome in place of AnisA. This strain had a Nisphenotype despite carrying an intact nisA gene. This result contrasts with that of an equivalent gene replacement experiment, with plasmid pFI690 (Fig. 1 b) , which generated the Nis' strain FI7898 (Table 1 ). The only difference between the two sequences involved is that FI8003 has an additional BamHI site incorporated 80bp upstream of the ATG start codon of nisA, and a BglrI site immediately downstream of the coding region. The BamHI site overlaps with the proposed -35 region of the promoter identified by Kuipers et al. (1993) and the single base pair change introduced as a result of engineering this restriction site has the effect of converting the -35 sequence from CTGATT to CCGATT (Fig. 2) . In pFI740, the natural nzsA promoter has been disrupted and hence FI8003, which has incorporated the BamHI site by gene replacement, has acquired the defective promoter.
Production of engineered nisins
The gene replacement strategy was successfully employed to select for several derivatives of FI7990 that are now exclusively producing engineered nisins in place of wildtype nisin. Strain FI8290, encoding the variant gene nisAlAM21, did not produce detectable levels of an active peptide. However, strains encoding the other mutated nisA genes in this study all generated a biologically active product (Table 1) which was purified to homogeneity allowing further characterization. Verification of the predicted changes to the nisin molecules was provided by electrospray mass spectrophotometry (C. J. Giffard & A.
Parr, unpublished data). 2-D NMR spectra of the engineered peptides Dha5A nisin A, Dha33A nisin A and Dha5A/Dha33A nisin A (W. C. Chan, B. W. Bycroft & G. C. K. Roberts, unpublished data) provided further structural verification and confirmed the lack of Dha residues in these molecules.
The activity of the engineered nisins, relative to wild-type nisin, was determined by calculating the MICs of the purified peptides. The results (Table 2) indicate that the Dha residues, in both the functionally important ring A (Chan e t al., 1989) and in position 33, are not critical for activity. However, the variant containing both mutations displays a significantly lower activity than nisin A (approximately tenfold lower against L. lactis and twofold lower against M. IuteuJ). H27K nisin A and K12L nisin A displayed the same MIC values as nisin A, indicating that these mutations had not affected the specific activity. The substitution of isoleucine for a tryptophan residue at position 30 was found to slightly diminish antimicrobial activity (Table 2) . Despite displaying a negligible decrease in activity, the yield of both I30W nisin A and K12L nisin A (in cell-free extracts) was significantly lower, approximately 1 and l o % , respectively, than that of wild-type levels. A parallel reduction in the immunity levels was also evident for strains expressing these variant nisA genes. All the other FI7990-derivatives were immune to wild-type levels of nisin (Table 1) .
DISCUSSION
A lactococcal expression system for engineering nisin has been developed which employs the technique of gene replacement. This system, as with the F17332 plasmidcomplementation approach (Dodd e t al., 1992) , achieves exclusive production of the engineered nisin. However, the genomes of engineered strains, generated by gene replacement, differ from wild-type only in the presence of the directed mutation and this minimal change has potential advantages over the former system for regulation and practical uses. As nisin biosynthesis is an autoinducible mechanism (Kuipers e t al., 1995) , the overall level of expression of the mature peptide is likely to be influenced by the effectiveness of that particular nisin variant as an inducing agent. Nevertheless, an advantage of the gene replacement approach is that by maintaining normal gene dosages the relative levels of expression of the individual genes within the nisin operon are likely to remain constant resulting in the correct balance of gene products. Furthermore, as complementation is not employed to recover a Nis' phenotype, this system does not suffer from the need to maintain plasmid-encoded functions.
Gene replacement is a valuable technique for the functional analysis of the bacterial genome, including that of L. lactis (Leenhouts etal., 1989 (Leenhouts etal., ,1990 Chopin etal., 1989) .
This approach has been used effectively in gene disruption experiments with Bacillus subtilis, investigating the role of spa genes involved in biosynthesis of the related lantibiotic subtilin (Klein e t al., 1992; Klein & Entian, 1994; Liu & Hansen, 1992) . In the course of the work with L.
lactis reported in the present paper it became evident that the expected ratios of gene replacement products were not being achieved. The protocol used involves the integration of the thermosensitive plasmid, pG+host6 in the chromosome, followed by its excision. Assuming that crossovers occur with equal frequency between homologous sequences on either side of the mutation, it would be predicted that, following pG'host6 excision, the numbers of cells carrying the introduced mutation and Strategy for protein engineering nisin those remaining identical to the parent strain would be the same. This did not prove to be the case and the majority of colonies screened retained the genetic organization of the parent strain FI7990. The reason for this is not clear, but it suggests that the immediate effect of integration of a functional nisA gene is detrimental to the host cell. It has been reported that expression of the nisA gene precedes that of the adjacent nisB gene by 30 min (Engelke e t al., 1994) and transcription of other determinants in the nisin gene cluster may be similarly delayed, with respect to prenisin production. Those strains that acquire a nisA gene by gene replacement may not have recovered full immunity before the nisin molecule exerts its antimicrobial action and hence growth would be impeded.
The deletion of the nisin promoter in FI7990 (Fig. le) generates a Nis-strain that cannot be complemented by provision of plasmid-encoded nisA, and which displays significantly reduced levels of immunity. This observation was fundamental to the development of an effective gene replacement method in that it facilitates the identification of FI7990-derivatives that express engineered nisin variants. The modified protocol uses recovery of full nisin immunity as a means of directly selecting those Nis' strains generated by gene replacement and relies on the fact that the parent strain will not grow on these selective plates. Nis-strains that retained the upstream promoter sequences (eg. by introduction of a frameshift mutation in nisA) were unsuitable as recipients for the gene replacement protocol. Whilst their immunity was also reduced, it was found that restoration of nisin immunity could be induced as a consequence of growing in the presence of 10 pg nisin ml-' in the selective medium (H.
M. Dodd & W. C. Chan, unpublished data) . Hence, these strains grew well at the levels of nisin that were found to be optimal for selection of Nis' recovery in FI7990. Primer-extension mapping of the nisA gene transcript has identified the promoter and the transcription start point (Kuipers et a/., 1993) . Experiments carried out with strains generated in this study confirm that the region upstream of nisA has promoter activity and underline the importance of the -35 region for expression of both nisin biosynthesis and immunity.
Protein engineering provides a powerful means of studying the structure-activity relationships of lantibiotics. The introduction of amino acid changes in nisin facilitates an investigation of the importance of specific residues and certain structural features of the peptide in its biological activity. The dehydro residues in nisin are a source of structural instability as shown by the production of spontaneous degradation products resulting from cleavage of the peptide bond at Dha, and Dha,, (Chan e t al., 1989) . It has recently been reported that substitution of Dha, for a dehydrobutyrine (Dhb,) generates a molecule displaying greater resistance to acid degradation (Rollema e t a/., 1995) . In addition, it has been proposed that equivalent Dha at position 5 in the related lantibiotic subtilin, is involved in the antimicrobial activity against outgrowth of bacterial spores (Liu & Hansen, 1993 . This is consistent with the proposal that the dehydro residues of lantibiotics play a role in an alternative mechanism of antimicrobial action directed against spore outgrowth (Liu & Hansen, 1993) .
Interest in developing alternative applications for nisin has prompted the construction of strains producing other variant molecules. H27K nisin A was generated with the intention of changing the biological properties of the wild-type molecule. The equivalent mutation in nisin 2 has recently been shown to result in a significant increase in solubility compared to the wild-type molecule (Rollema e t al., 1995) . Other nisin variants have been specifically designed with the purpose of furthering investigations into the mode of action of nisin. With K12L nisin A, the effect of increasing the overall positive-charge of the molecule is being investigated in phospholipid bilayer studies. The introduction of a tryptophan residue in I30W nisin A allows a fluorescent marker to be incorporated into the molecule facilitating the analysis of interaction of nisin with the membrane surface.
Strains producing the three nisin variants containing Dha + Ala substitutions (Table 1) have been constructed using both the FI7332 plasmid-complementation system (Dodd e t al., 1992 (Dodd e t al., , 1995 and the gene replacement approach described here. A comparison of the relative yields of antimicrobial activity generated by these two systems (in cell-free supernatants) indicated that the latter production host always gave higher values for each variant (determined in plate diffusion bioassays). In the case of the wild-type nisA gene, plasmid-complementation in the host strain FI7332 gave rise to approximately half the yield of nisin found with the parent strain FI5876. The difference between the levels of production was surprisingly more pronounced for the nisin variants. The gene replacement approach increased the Dha5A nisin A yield approximately fourfold and for Dha33A nisin A the yield was over tenfold higher. The increased efficiency of production of the double mutant DhaSA/Dha33A nisin A was particularly striking. When the gene that specified this variant nisin was plasmid-encoded and used to complement the host strain's nisA-deficiency, antimicrobial activity was only detected in the more sensitive colony overlay assay (Dodd e t al., 1995) . However, when the gene was incorporated into the chromosome the level of antimicrobial activity was equivalent to that of nisin A. The reason for this is not clear; however, these obser-vations underline the limitations of the FI7332 expression system that employs plasmid-complementation for production of nisin (Dodd e t al., 1992 (Dodd e t al., , 1995 . The insertional inactivation of n i s A suffered by this strain is thought to have resulted in the introduction of a constitutive promoter for the nisin operon (Dodd e t al., 1992) . In contrast, the equivalent Nis' FI7990-derivatives, generated by gene replacement, will still be subject to the same autoinduction mechanism as the wild-type strain .
Theoretically many different types of alterations could be introduced into the nisin molecule using the protein engineering approach. The system described here may, in practice, be limited to the production of only those variants that are not antagonistic towards the production strain and respond to the hosts' maturation and immunity machinery. An additional consideration is the requirement, by this expression system, for autoinduction by the mature nisin molecule in the external medium. It has been demonstrated that the antimicrobial activity of nisin variants and their ability to induce expression of the nisin operon are not directly related (Kuipers e t al., 1995) . Consistent with this is the discovery that K12L nisin A, which retains the specific activity of wild-type nisin, and I30W nisin A, which is slightly less active (Table 2) , do not function as effectively as inducing agents (H. M. Dodd, N. Horn & C. J. Giffard, unpublished data). The production levels of these strains were found to be much lower than the parent strain. However, this could be remedied by carrying out the fermentations in the presence of inducing levels of nisin. These strains also displayed lower levels of nisin immunity (Table 1) consistent with the proposed genetic link between biosynthesis and immunity (Kuipers e t a/., 1993; Dodd et al., 1992) . Similar attempts to induce detectable levels of activity by strain FI8290, encoding nisA/AM21, were not successful. This may imply that the antimicrobial activity of this nisin variant has been lost as a result of a deletion of the methionine residue at position 21. However, an investigation of the gene expression levels in this strain is needed to support this interpretation.
In the search for altered nisins displaying more efficient or beneficial properties under different conditions, the approach described here increases the likelihood of achieving antimicrobial activity and genetic stability in any engineered strains. In addition, the development of a nisA cassette vector extends the possible ways in which gene replacement can be used to adapt and exploit the existing nisin biosynthesis mechanism.
